Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$17.46 - $21.61 $3.39 Million - $4.2 Million
-194,284 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$17.35 - $22.5 $3,955 - $5,130
228 Added 0.12%
194,284 $3.74 Million
Q2 2021

Aug 16, 2021

SELL
$18.01 - $28.32 $1.22 Million - $1.92 Million
-67,631 Reduced 25.84%
194,056 $4.27 Million
Q1 2021

May 12, 2021

BUY
$19.76 - $29.89 $3.97 Million - $6.01 Million
201,024 Added 331.38%
261,687 $6.8 Million
Q4 2020

Feb 02, 2021

BUY
$15.73 - $21.66 $954,228 - $1.31 Million
60,663 New
60,663 $1.15 Million
Q1 2020

Apr 09, 2020

SELL
$5.57 - $11.5 $1.25 Million - $2.58 Million
-224,034 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$7.9 - $10.14 $1.77 Million - $2.27 Million
224,034 New
224,034 $2.24 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.